Latest Bryan, Garnier & Co news

Healthcare Projections - March 2017

Welcome to Bryan, Garnier & Co’s March 2017 Healthcare newsletter

Published last April Tuesday 4, 2017

Upon pricing its landmark IPO on Euronext Paris led by Sole Global Coordinator Bryan, Garnier & Co, Symetis is acquired by Boston Scientific for USD 435 million

Having completed its IPO roadshow, closed books, and established the official IPO price, Symetis, the leading European structural heart player, received a definitive, all-cash offer from Boston Scientific to purchase the Company

Published last March Thursday 30, 2017

Bryan, Garnier & Co advises Eudonet – a leading CRM SaaS company – on its sale to Quilvest Private Equity and Antoine Henry, former CEO of Sage France

Published last March Wednesday 29, 2017

Bryan, Garnier & Co, the leading European investment bank for growth companies, becomes a partner of the 2017 Tech Tour Growth Forum

Published last March Tuesday 28, 2017

Bryan, Garnier & Co advises the shareholders of Agence79 on its sale to Havas Group

Published last March Thursday 23, 2017

Automotive Technologies

Welcome to the first in a new series of “Market Watch" reports about the Automotive sector

Published last March Monday 20, 2017

Bryan, Garnier & Co advises La Banque Postale on its acquisition of Domiserve, leading provider of personal services payment vouchers

Published last March Friday 17, 2017

Bryan, Garnier & Co hires Charles Tellier to head up Consumer and Retail division

Published last March Wednesday 15, 2017

Bryan, Garnier & Co hires leading expert in Consumer and Retail as Executive Advisor

Published last March Thursday 9, 2017

Bet on Insurance Software

Welcome to the first of a new series of “Projections” newsletters

Published last February Tuesday 28, 2017

Bryan, Garnier & Co's News